Ceftolozane/Tazobactam: a new option in the treatment of complicated gram-negative infections.

September 18, 2015 at 3:32 pm

P T. 2014 Dec;39(12):825-32.

Sorbera M, Chung E, Ho CW, Marzella N.

Abstract

Ceftolozane/tazobactam: a new option in the treatment of complicated gram-negative infections.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264669/pdf/ptj3912825.pdf

 

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Health Care-Associated Infections, Infecciones nosocomiales, Metodos diagnosticos, Resistencia bacteriana, Sepsis, Update. Tags: .

Colonization with resistant microorganisms in patients transferred from abroad: who needs to be screened? Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections.


Calendar

September 2015
M T W T F S S
« Aug   Oct »
 123456
78910111213
14151617181920
21222324252627
282930  

Most Recent Posts


%d bloggers like this: